Others Products Targets
- Other Nuclear Receptors (6)
- Vitamin D Receptor (10)
- Apelin Receptor (5)
- Thyrotropin-Releasing Hormone Receptor (1)
- Somatostatin (sst) Receptor (14)
- Progesterone Receptor (4)
- Parathyroid Hormone Receptor (1)
- PACAP Receptor (3)
- NPY Receptor (22)
- Natriuretic Peptide Receptor (4)
- Motilin Receptor (3)
- Mineralocorticoid Receptor (7)
- Melatonin Receptor (10)
- Melanocortin (MC) Receptor (17)
- Leptin Receptor (1)
- Kisspeptin Receptor (4)
- Insulin and Insulin-like Receptors (9)
- Gonadotropin-Releasing Hormone Receptor (3)
- Ghrelin Receptor (12)
- Galanin Receptor (11)
- Estrogen and Related Receptor (33)
- Calcitonin and Related Receptor (10)
- Bombesin Receptor (12)
- OX2 Receptor (4)
- OX1 Receptor (5)
- Secretin Receptor (1)
- Glucagon-Like Peptide 2 Receptor (2)
- Glucagon-Like Peptide 1 Receptor (7)
- Glucagon Receptor (3)
- Androgen Receptor (11)
- GIP Receptor (1)
- CRF2 Receptor (3)
- CRF1 Receptor (5)
- CCK2 Receptor (7)
- CCK1 Receptor (3)
- VIP Receptor (7)
- ETB Receptor (6)
- ETA Receptor (5)
- Angiotensin AT2 Receptor (3)
- Angiotensin AT1 Receptor (9)
Products for Others - Page 10
- Cat.No. Product Name Information/Activity
-
BCC7826
YIL 781
875258-85-8
-
BCC6010
Cortistatin 14
Cortistatin 14, human, rat (CST-14, human, rat), a neuropeptide with neuronal depressant and sleep modulating properties, can bind to all five cloned somatostatin receptors (SSTRs) and ghrelin receptor to exert its biological activities and co-exists with GABA within the cortex and hippocampus.
-
BCC5953
[Des-octanoyl]-Ghrelin (rat)
307950-60-3
![[Des-octanoyl]-Ghrelin (rat) chemical structure](/media/images/struct/BCC5953.png)
-
BCC7304
[Des-octanoyl]-Ghrelin (human)
313951-59-6
![[Des-octanoyl]-Ghrelin (human) chemical structure](/media/images/struct/BCC7304.png)
-
BCC7464
AG 045572
Selective GnRH receptor antagonist
-
BCC7395
T 98475
199119-18-1
-
BCC7802
WAY 207024 dihydrochloride
GnRH receptor antagonist
-
BCC1177
BMS-536924
BMS-536924 is an orally active, competitive and selective insulin-like growth factor receptor (IGF-1R) kinase and insulin receptor (IR) inhibitor with IC50s of 100 nM and 73 nM, respectively. BMS-536924 has anti-cancer activity.
-
BCC3787
GSK1838705A
GSK1838705A is a potent and reversible IGF-IR and the insulin receptor inhibitor with IC50s of 2.0 and 1.6 nM, respectively. It also inhibits ALK with an IC50 of 0.5 nM.
-
BCC4553
NVP-ADW742
NVP-ADW742 (ADW742) is an orally active, selective IGF-1R tyrosine kinase inhibitor with an IC50 of 0.17 μM. NVP-ADW742 inhibits insulin receptor (InsR) with an IC50 of 2.8 μM. NVP-ADW742 induces pleiotropic antiproliferative/proapoptotic biologic sequelae in tumor cells.
